New polyglycolic acid fabric for the prevention of postoperative pancreatic fistulas

Asian J Surg. 2018 Jan;41(1):59-64. doi: 10.1016/j.asjsur.2016.08.001. Epub 2016 Sep 17.

Abstract

Background: The incidence of postoperative pancreatic fistula (POPF) after distal pancreatectomy is approximately 30%. The most serious complications of pancreatic resection, such as mortality and prolonged hospitalization, are unresolved despite the proposal of various surgical procedures. We developed a new polyglycolic acid (PGA) fabric composed of fine diameter fibers to prevent POPF, and macroscopically and microscopically evaluated the effects of applying it to the pancreatic remnant.

Methods: The ventral pancreatic surface was cauterized to create the experimental model of POPF in 33 female Wistar/ST rats. The injured sites were wrapped with nonwoven PGA fabrics of different fiber diameters and porosities in the treated rats; one group of rats remained untreated. Survival, incidence of generalized peritonitis, and microscopic findings around the pancreas were investigated.

Results: The PGA fabrics acted as a scaffold for tissue repair and resulted in superior survival. Generalized peritonitis was milder in the PGA treated groups. With the new PGA fabric, abundant fibroblast infiltration and a uniformly-developed, self-organized barrier wall prevented both pancreatic leak and spread of inflammation.

Conclusion: Application of the newly developed PGA fabric to the pancreatic remnant prevented POPF, and the essential factor for preventing pancreatic leak was the early formation of a self-organized barrier.

Keywords: distal pancreatectomy; pancreatic surgery; polyglycolic acid; postoperative pancreatic fistula; scaffold.

MeSH terms

  • Animals
  • Female
  • Guided Tissue Regeneration / methods*
  • Pancreatectomy*
  • Pancreatic Fistula / etiology
  • Pancreatic Fistula / prevention & control*
  • Polyglycolic Acid*
  • Postoperative Complications / prevention & control*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Tissue Scaffolds*
  • Treatment Outcome

Substances

  • Polyglycolic Acid